CNSP (CNS Pharmaceuticals) FCF Margin %: 0.00% (As of Mar. 2026)


CNSP CNS Pharmaceuticals Inc CNSP
30 GF Score
Price $3.98
! 1 Warning Sign
View Full Analysis

What is CNS Pharmaceuticals FCF Margin %?

CNS Pharmaceuticals CNSP -4.14% 30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates CNSP with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, CNS Pharmaceuticals ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CNS Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was $-4.66 Mil. CNS Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, CNS Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, CNS Pharmaceuticals's current FCF Yield % is -261.72%.

The historical rank and industry rank for CNS Pharmaceuticals's FCF Margin % or its related term are showing as below:


CNSP's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

CNS Pharmaceuticals FCF Margin % Related Terms

CNS Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for CNS Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNS Pharmaceuticals FCF Margin % Chart

CNS Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

CNS Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CNSP vs SYBX, ELAB, GNPX: FCF Margin % Comparison

For the Biotechnology subindustry, CNS Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNS Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNS Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CNS Pharmaceuticals's FCF Margin % falls into.


CNSP
30GF Score
CNS Pharmaceuticals Inc CNSP
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CNS Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CNS Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.829/0
= %

CNS Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.655/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
CNS Pharmaceuticals (CNSP) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CNS Pharmaceuticals and its competitors. According to the industry distribution chart, CNS Pharmaceuticals ranks #999999 out of 959 companies in the Biotechnology industry.
Is CNS Pharmaceuticals' FCF Margin % too high?
CNS Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, CNS Pharmaceuticals ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CNS Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does CNS Pharmaceuticals' FCF Margin % compare to SYBX and ELAB?
According to the Biotechnology industry distribution chart, CNS Pharmaceuticals ranks #999999 out of 959 companies for FCF Margin %. This places CNS Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CNS Pharmaceuticals and its competitors. CNS Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Pharmaceuticals stock overvalued right now?
CNS Pharmaceuticals (CNSP) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. CNS Pharmaceuticals' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CNS Pharmaceuticals (CNSP), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CNS Pharmaceuticals Business Description

Address 2100 West Loop South, Suite 900, Houston, TX, USA, 77027
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
30GF Score

Get the complete analysis for CNSP

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.98
Price